Sort by
Quarterly Activities/Appendix 4C Cash Flow Report
Annual Report (Typeset)
Peer-Reviewed Study Reports 100% Disease Control
Change of Director's Interest Notice
Notification of cessation of securities - OSL
Updated OSPREY Overall Survival Data Presented at EAMN
Notice of Annual General Meeting/Proxy Form
Application for quotation of securities - OSL
PALACROS Officially Launched in Amsterdam
OncoSil Clinical Data to be Presented at EANM 2026
| Date | Headline |
|---|---|
30 Oct 2026 | Quarterly Activities/Appendix 4C Cash Flow Report |
27 Oct 2026 | Annual Report (Typeset) |
27 Oct 2026 | Peer-Reviewed Study Reports 100% Disease Control |
26 Oct 2026 | Change of Director's Interest Notice |
26 Oct 2026 | Notification of cessation of securities - OSL |
21 Oct 2026 | Updated OSPREY Overall Survival Data Presented at EAMN |
19 Oct 2026 | Notice of Annual General Meeting/Proxy Form |
15 Oct 2026 | Application for quotation of securities - OSL |
13 Oct 2026 | PALACROS Officially Launched in Amsterdam |
30 Sep 2026 | OncoSil Clinical Data to be Presented at EANM 2026 |